rs4444903
A SNP in the EGF gene on chromosome 4. Its most notable genotype is G;G: 3.5x risk of hep-cancer in cirrhosis patients; higher glioma risk; 3x higher gallbladder cancer risk in females
- Gene
- EGF
- Location
- Chr 4109,912,954 (GRCh38)
- Highest magnitude
- 2.1Worth knowing
- Tested on
- 23andMe, AncestryDNA, FamilyTreeDNA
- Minor allele frequency
- 42%
Genotypes
As shown in 23andMe and AncestryDNA files.
- A;AGoodaverage
- A;GBad3.5x risk of hep-cancer in cirrhosis patients; higher glioma risk
- G;GMost notableBad3.5x risk of hep-cancer in cirrhosis patients; higher glioma risk; 3x higher gallbladder cancer risk in females
On SNPedia: (A;A), (A;G), (G;G). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Related
Conditions, medicines and genes
Notes
From SNPedia
Show notes, about 420 words
rs4444903 is a SNP, also known as +61, located in the promoter region of the epidermal growth factor EGF gene that influences the amount of EGF produced. The rs4444903(G) allele appears to produce higher amounts of EGF than the (A) allele. A study of 2 Caucasian populations of patients with alcoholic cirrhosis indicates that, for these patients, the presence of the risk allele rs4444903(G) increases the chances of developing hepatocellular carcinoma (liver cancer). After adjusting for age, sex, race, etiology, and severity of cirrhosis the number of (G) copies led to an odds ratio for either (G;G) or (A;G) genotypes versus the (A;A) genotype of 3.49 (CI: 1.29-9.44, p=.01). In another study, analysis of 197 glioma patients showed that the rs4444903(G) allele conferred higher risks for gliomas (odds ratio 1.32, CI: 1.04-1.67), glioblastomas (OR, 1.47, CI: 1.02-2.10), and oligodendrogliomas (OR, 1.55, CI: 1.07-2.23). In general, the risk was about the same for a carrier or one or two (G) alleles, however, no significant association was observed with patients' overall survival. A study of 126 Indian gallbladder cancer patients concluded that the rs4444903(G;G) genotype was at increased risk, but only in females (odds ratio 3.45, CI: 1.52-7.82, p = 0.003). effects lots of no known risk pmids15373782 15729146 16214932 16214933 16214934 16214935 16217151 16217152 16217153 rs4444903, rs2298991, rs7692976 and rs4533485 significantly interacted with gender for acute respiratory distress syndrome risk. popular in pubmed Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Development of a fingerprinting panel using medically relevant polymorphisms. Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection.
Source and license
Adapted from rs4444903 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.